Namrata Setia to Immunotherapy
This is a "connection" page, showing publications Namrata Setia has written about Immunotherapy.
Connection Strength
0.159
-
Diagnostic Challenges due to a Germline Missense MSH2 Variant in a Patient With Immunotherapy-Responsive Locally Advanced Rectal Adenocarcinoma. Cancer Rep (Hoboken). 2024 Dec; 7(12):e70037.
Score: 0.159